Myasthenia Gravis is a chronic disorder characterized by weakness and rapid fatigue of any of the muscles under your voluntary control. Myasthenia Gravis is caused by a breakdown in the communication between nerves and muscles, usually because of an immunological problem where the cells cannot communicate and the immune system attacks cells it does not recognize. There are 86 autoimmune diseases that have been diagnosed today and Myasthenia Gravis is one of them.
Facial muscle weakness, including drooping eyelids
Difficulty in breathing, talking, chewing or swallowing
Muscle weakness in your arms or legs
Fatigue brought on by repetitive motions.
The treatments of this disease focus on altering one’s immune system so that fewer antibodies are produced and therefore the muscle can rebuild its acetylcholine receptors. Perhaps the most commonly used initial medication is prednisone. In addition many patients will take a medication called mestinon or celcept. This does not treat the underlying problem but can improve the Myasthenia Gravis symptoms. Medications are basically to suppress the immune system to stop the production of antibodies that kill the cells.
Recent research in the field of glycobiology has brought about a discovery in cellular communication that has won several Nobel Prizes in medicine. A recent press release from Emory University School of Medicine announced the appointment of Dr. Richard Cummings, as the new chair of the Department of Biochemistry at Emory University. The article states that “the National Institutes of Health has identified the field of glycomics as a major new research focus. Glycomics is defined as the scientific pursuit of identifying and studying all of the carbohydrate molecules produced by an organism. Dr. Cummings’ research focuses on glycoconjugates, the carbohydrate molecules and their associated proteins that permit cells to communicate with and adhere to each other — transmitting and receiving chemical, electrical and mechanical messages that underlie all cellular and bodily functions.”
The primary function of the glyconutrients is the communication between cells, which “underlies all bodily functions.” There is a tremendous amount of research ongoing by many prestigious institutions. It is very exciting to see that Emory University School of Medicine has joined this endeavor. It is exciting that two major universities (“The Complex Carbohydrate Center” at UGA and Emory School of Medicine) are now at the forefront of this new frontier in medicine–the science of Glycobiology.
Due to green harvesting of fruits and vegetables, toxins in the air, food, and water, and the processing of our foods, the health of the world today is on a decline and we must supplement vitamins, minerals, essential fatty acids, amino acids, and now it has been shown that we also need the glyconutrients. If we do not receive the glyconutrients in our diet we will get sick either by the body leaving bad cells or not recognizing the good cells and attacking them.
A form of nutrition called glyconutrients has been shown to give the body what it needs to develop healthy cells that can communicate and therefore the body can respond as it was designed to do.